Form 4 for BDC BELDEN INC.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-04 · accession 0001193125-25-311352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-08 | 2025-12-04 | BDC | Lieser Brian | EVP, Solutions | D - Sale to Iss | $120.70 | -3,681 | 30.1K | -11% | -$444.3K |
| DT | 2025-12-08 | 2025-12-05 | BDC | Lieser Brian | EVP, Solutions | S - Sale+OE | $120.00 | -1,270 | 29.1K | -4% | -$152.4K |
| DMT | 2025-12-08 | 2025-12-04 | BDC | Lieser Brian | EVP, Solutions | M - OptEx | $63.64 | +4,951 | 31.6K | +19% | +$315.1K |
| DMT | 2025-12-08 | 2025-12-04 | BDC | Lieser Brian | EVP, Solutions | M - OptEx | $0.00 | -4,951 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | D | D | 961 | $120.70 | 30,344 | D | — | — | (F5) This represents the difference between the number of SARs exercised (1,225) and the number of shares issued as a result of the exercise (264). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 2 | Common | Common Stock | 2025-12-05 | S | D | 1,270 | $120.00 | 29,074 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-04 | D | D | 1,759 | $120.70 | 29,831 | D | — | — | (F3) This represents the difference between the number of SARs exercised (2,516) and the number of shares issued as a result of the exercise (757). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 4 | Common | Common Stock | 2025-12-04 | M | A | 1,210 | $74.91 | 31,041 | D | — | — | |
| 5 | Common | Common Stock | 2025-12-04 | D | D | 961 | $120.70 | 30,080 | D | — | — | (F4) This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (249). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($74.91). Additional shares were then withheld to satisfy the Company's tax withholding obligations. |
| 6 | Common | Common Stock | 2025-12-04 | M | A | 1,225 | $72.73 | 31,305 | D | — | — | |
| 7 | Common | Common Stock | 2025-12-04 | M | A | 2,516 | $53.79 | 31,590 | D | — | — | |
| 8 | Derivative | Stock Appreciation Rights | 2025-12-04 | M | D | 1,225 | $0.00 | 0 | D | $72.73 · — to 2028-02-28 | 1,225 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |
| 9 | Derivative | Stock Appreciation Rights | 2025-12-04 | M | D | 1,210 | $0.00 | 0 | D | $74.91 · — to 2027-02-22 | 1,210 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |
| 10 | Derivative | Stock Appreciation Rights | 2025-12-04 | M | D | 2,516 | $0.00 | 0 | D | $53.79 · — to 2032-02-22 | 2,516 Common Stock | (F7) The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date. |